Výsledky vyhledávání - "Renan A. Bonnel"

Comparison of Reporting of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Selective COX-2 Inhibitors

Autor: Claudia B. Karwoski, Renan A. Bonnel, Allen Brinker, Joyce Weaver, Lauren Lee, Lois La Grenade, Laura Governale

Publikováno v: Drug Safety. 28:917-924

Background: Stevens-Johnson syndrome and toxic epidermal necrolysis are closely related severe acute life-threatening, drug-induced skin disorders. The US FDA Adverse Events Reporting System (AERS) has received reports of Stevens-Johnson syndrome and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1af84067015df40a20c3fbfcd84620f9
https://doi.org/10.2165/00002018-200528100-00008

Zobrazit plný text záznamu

Peripheral neuropathy in patients treated with leflunomide*1

Autor: Renan A. Bonnel, David J. Graham

Publikováno v: Clinical Pharmacology & Therapeutics. 75:580-585

Objective Our objective was to describe the clinical features, time course, and outcome of new-onset peripheral neuropathy occurring in patients treated with leflunomide. Methods Case reports of peripheral neuropathy submitted to the US Food and Drug

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::da4fa2e75c7aa23718646076d04449be
https://doi.org/10.1016/j.clpt.2004.01.016

Zobrazit plný text záznamu

Peripheral neuropathy in patients treated with leflunomide

Autor: Renan A, Bonnel, David J, Graham

Publikováno v: Clinical pharmacology and therapeutics. 75(6)

Our objective was to describe the clinical features, time course, and outcome of new-onset peripheral neuropathy occurring in patients treated with leflunomide.Case reports of peripheral neuropathy submitted to the US Food and Drug Administration in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ab0fadea6772143701fdac33ba9a88b5
https://pubmed.ncbi.nlm.nih.gov/16003297

Zobrazit plný text záznamu

Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozin

Autor: Lawrence Goldkind, Renan A. Bonnel, Allen Brinker, Julie Beitz

Publikováno v: Drugsaging. 21(7)

Data on file with the US FDA, and other published studies, suggest that the selective cyclo-oxygenase (COX)-2 inhibitor NSAID rofecoxib has a greater hypertensive adverse effect than other NSAIDs, including celecoxib. In this study we describe a phar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23652f57a2f88676bb1f79a69ea2ee61
https://pubmed.ncbi.nlm.nih.gov/15132714

Zobrazit plný text záznamu

Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience

Autor: Claudia B. Karwoski, Lois La Grenade, Renan A. Bonnel, Julie Beitz

Publikováno v: Journal of the American Academy of Dermatology. 48(2)

A total of 26 postmarketing cases of allergic contact dermatitis to doxepin 5% cream were reported to the Food and Drug Administration. Our findings suggest that allergic contact dermatitis was more common when treatment duration exceeded the recomme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93064c018ecfe8ee12f6bcd5980403f6
https://pubmed.ncbi.nlm.nih.gov/12582408

Zobrazit plný text záznamu

Deaths associated with inappropriate intravenous colchicine administration

Autor: Maria L. Villalba, Julie Beitz, Claudia B. Karwoski, Renan A. Bonnel

Publikováno v: The Journal of emergency medicine. 22(4)

Intravenous (IV) colchicine is occasionally prescribed for the treatment of acute gouty arthritis. The Food and Drug Administration (FDA) recently received a report of death in a patient that was associated with inappropriate IV dosing of colchicine.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a0b3c11e5af03470e2c029b1d6bddd1
https://pubmed.ncbi.nlm.nih.gov/12113850

Zobrazit plný text záznamu

Aseptic meningitis associated with rofecoxib

Autor: Maria L. Villalba, Claudia B. Karwoski, Julie Beitz, Renan A. Bonnel

Publikováno v: Archives of internal medicine. 162(6)

Rofecoxib is a nonsteroidal anti-inflammatory drug that is reported to act by selectively inhibiting cyclooxygenase-2. A review and analysis of reports sent to the Spontaneous Reporting System of the Food and Drug Administration, Rockville, Md, sugge

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fff405d088343abce0bc1221d4133958
https://pubmed.ncbi.nlm.nih.gov/11911727

Zobrazit plný text záznamu

Re: postmarking adverse events related to sotradecol (sodium tetradecyl sulfate-sclerosing agent)

Autor: Renan A. Bonnel

Publikováno v: The American Journal of Gastroenterology. 97:2140-2140

Re: postmarking adverse events related to sotradecol (sodium tetradecyl sulfate-sclerosing agent)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d07adca6201995929d044525fe8aba16
https://doi.org/10.1111/j.1572-0241.2002.05936.x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání